Role of AT-rich interaction domain 1A in gastric cancer immunotherapy: Preclinical and clinical perspectives.

Zhang, Xuemei; Zhang, Youzhi; Zhang, Qiaoyun; Lu, Mengyao; Chen, Yuan; Zhang, Xiaoyu; Zhang, Peng.

Afiliação

Zhang X; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zhang Y; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zhang Q; School of Pharmacy, Hubei University of Science and Technology, Xianning, China.
Lu M; School of Pharmacy, Hubei University of Science and Technology, Xianning, China.
Chen Y; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zhang X; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zhang P; Division of Gastrointestinal Surgery, Department of General Surgery, Huai'an Second People's Hospital, the Affiliated Huai'an Hospital of Xuzhou Medical University, Huaian, China.

J Cell Mol Med ; 28(5): e18063, 2023 Dec 02.

Article em En | MEDLINE | ID: mdl-38041544